What is it about?
Analysis of pathogenesis on immunomodulation in patients with liver cancer(HCC).
Featured Image
Why is it important?
The inflammatory cytokine including IL-16 in HCC promotes tumor aggravation.
Perspectives
To target of cytokine may contribute to new strategies for HCC therapy.
Yuko Takeba
Read the Original
This page is a summary of: Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach, Tumor Biology, December 2021, IOS Press,
DOI: 10.3233/tub-211507.
You can read the full text:
Contributors
The following have contributed to this page
